Join
Live feed
·
PRReleasevia Quantisnow
CorMedix Inc. logo

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

ByQuantisnow·Wall Street's wire, on your screen.
CRMD· CorMedix Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRMD (CorMedix Inc.) and more on Quantisnow.